Clinical Trials for OncoResponse

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: OncoResponse

Clinical Trials (2)

NCT06090266
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
PHASE1/PHASE2Recruiting
168 participants
Started: Oct 24, 2023 · Completed: Feb 1, 2027
7 conditions1 sponsor4 locations
NCT05094804
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
PHASE1/PHASE2Recruiting
172 participants
Started: Sep 9, 2021 · Completed: Aug 15, 2024
10 conditions1 sponsor3 locations